Cytarabine is a chemotherapy agent used primarily in the treatment of acute myeloid leukemia (AML) and non-Hodgkin's lymphoma. It is a cytosine nucleoside analog that interferes with DNA synthesis in rapidly dividing cells. Administered intravenously or intrathecally, it is particularly effective in hematological malignancies. Side effects can include bone marrow suppression, nausea, and neurotoxicity.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Cytarabine and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Cytarabine impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Cytarabine-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
